PubReading [109] - Novel therapeutic targets for cancer metastasis - K. Stoletov, P. Beatty and J. Lewis

The development of metastatic disease is a complex interplay of genetic and epigenetic factors from the host and cancer cells acting in a patient-specific manner. Inhibiting key driver traits of metastasis should yield survival benefit at any stage of the disease, and we look forward to the next generation of personalized medicines for cancer therapy that target cancer cell motility for increased therapeutic efficacy. - doi.org/10.1080/14737140.2020.1718496 - 2020